Flexible Solutions International, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FSI research report →
Price Chart
About the company
Flexible Solutions International, Inc. , headquartered in Taber, Canada, operates as a global enterprise focused on the development, manufacturing, and distribution of specialized chemicals primarily aimed at reducing water evaporation. The company's operations are divided into two main areas: Energy and Water Conservation Products, and Biodegradable Polymers.
- CEO
- Daniel O'Brien
- IPO
- 1999
- Employees
- 78
- HQ
- Taber, AB, CA
Get TickerSpark's AI analysis on FSI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $81.07M
- P/E
- -25.96
- Fwd P/E
- 13.25
- PEG
- 0.13
- P/S
- 2.28
- P/B
- 2.19
- EV/EBITDA
- -273.34
- Div Yield
- 0.00%
- Gross Margin
- 16.24%
- Op Margin
- -5.61%
- Net Margin
- -8.76%
- ROE
- -8.12%
- ROIC
- -3.89%
Latest fiscal year · YoY change
- Revenue
- $38.52M+0.7%
- Gross Profit
- $8.70M-34.3%
- Op Income
- $3.57M
- Net Income
- $786.89K-74.1%
- EPS
- $0.06-74.1%
- OCF Growth
- -32.1%
- FCF Growth
- -198.0%
- 52W High
- $9.89
- 52W Low
- $4.85
- 50D MA
- $5.52
- 200D MA
- $5.92
- Beta
- 1.72
- RSI (14)
- 73
- Avg Volume
- 18.39K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Flexible Solutions posted a Q2 loss as food-grade and Panama scale-up costs weighed on results, but management expects a strong Q3 rebound driven by new food contracts and recovered FL LLC sales rights.· August 17, 2026
- Q2 sales fell 14% year over year to $7.60 million from $8.87 million, and the quarter posted a loss of $1.91 million, or $0.15 per share.
- Management said the prior-year quarter included $2.5 million of irregular R&D revenue that did not recur, so recurring revenue was higher year over year.
- The January 2025 food contract is ramping, the August 2025 food contract is at full production, and management expects significant Q3 and faster Q4 revenue growth.
- Dan O'Brien said the company expects Q3 profitability, with profits increasing rapidly in Q4, and emphasized no need for equity financing.
- Management said FL LLC-related customer business is already returning directly, with revenue recovery expected at $5 million to $7 million annually over the next 12 months.
Second-quarter 2026 sales were $7.60 million, down 14% from $8.87 million in Q2 2025. The company reported a loss of $1.91 million, or $0.15 per share, versus a gain of $2.03 million, or $0.16 per share, a year ago. Management said Q2 2025 included $2.5 million of irregular R&D revenue that did not recur this year, so recurring revenue was higher year over year. For the August 2025 food contract, management said it has reached full production, while the January 2025 contract started volume production very late in Q2 and should show significant revenue in Q3 and increase rapidly in Q4. Management also reiterated full-year-style expectations for Q3 profitability and rapidly increasing profits in Q4, with food-division margins targeted at 22% to 25% before tax and wine-contract margins around 25% to 26%.
Dan O'Brien framed the quarter as a transition period, saying the company is building out food-grade capacity and shifting NCS toward food and nutraceutical products only by the end of 2026. He was upbeat on the new contracts, saying the August contract is at full capacity, the January contract is ramping, and both should support stronger Q3 and Q4 results. He also pointed to Panama as a future revenue/profit contributor and said FL LLC-related sales are already returning through direct customer relationships and former representatives.
O'Brien said scale-up expenses in Illinois and Panama were expensed as incurred, which hurt Q2 profitability, and he linked the loss to training and ramping labor across the new food contracts. He said the company is carrying more inventory, partly by choice, to take advantage of lower input prices, and noted raw material and shipping costs remain volatile because of tariffs and the Iran war. On balance sheet and capital, he said long-term debt is being paid down, working capital is adequate, lines of credit remain available, and the company does not expect to need equity actions. He also guided to gross margins of 22% to 25% before tax for the newer food contracts, 25% to 26% for the wine contract, and 15% to 17% net margin after tax for the newer food contracts.
Analysts asked about the inventory build, receivables decline, food-contract ramp, and the status of the shelf offering. Management said the inventory build was intentional, tied to cyclical raw-material buying, Panama, and food-grade inventory needs, and said the shelf is simply being kept available for a compelling acquisition, not for current use. On the biggest food contract, O'Brien said revenue should show materially in Q3 because finished goods are already being billed, while the August contract is at full capacity but still being optimized for profitability. On FL LLC, he said the company is already taking direct orders from historical customers and expects $5 million to $7 million of annual revenue recovery over the next 12 months.
The call pointed to multiple near-term growth drivers: the January food contract is ramping, the August contract is at full production, and management said Q3 should show material revenue with profits turning positive. FL LLC rights are already producing direct orders again, and management expects that business to recover over the next year. Panama and ENP were also described as stronger contributors in Q3 and beyond.
Q2 profitability was hit by expensive scale-up costs, labor inefficiencies, and lower-than-expected utilization at the new food operations. Management also highlighted ongoing tariff pressure, unstable shipping and raw material costs, and said the agriculture market remains under extreme pressure with 2026 still expected to be difficult for ENP. The food contracts were won with lower margins than management prefers, and the company said some revenue recovery from FL LLC will not be immediate.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 63.4%
- Shares Outstanding
- 12.75M
- Float Shares
- 8.09M
of shares held by institutions
31 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Renaissance Technologies LLC | 329.75K | ▼ 11.19K |
| Vanguard Group Inc | 284.87K | 0 |
| Vanguard Capital Management LLC | 282.12K | ▲ 3.96K |
| Perritt Capital Management Inc | 108.20K | ▲ 600 |
| Dimensional Fund Advisors LP | 96.12K | ▲ 3.84K |
| North Star Investment Management Corp. | 90.00K | 0 |
| Beartown Capital Management, LLC | 74.75K | 0 |
| Regal Investment Advisors LLC | 43.19K | 0 |
| Citadel Advisors LLC | 41.51K | ▲ 4.28K |
| Sentinus, LLC | 30.30K | ▲ 11.60K |
| Essex Investment Management Co LLC | 26.18K | ▼ 72 |
| Blackrock, Inc. | 25.24K | ▲ 5.46K |
Held by 24 ETFs
Biggest fund positions in FSI by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 19, 26 | Helina Robert Thomas | other | 10,000 |
| Feb 3, 26 | O BRIEN DANIEL B | sell | 16,497 |
| Feb 3, 26 | O BRIEN DANIEL B | sell | 12,500 |
| Jan 27, 26 | O BRIEN DANIEL B | sell | 56,000 |
| Jan 28, 26 | O BRIEN DANIEL B | sell | 45,500 |
| Nov 16, 23 | O BRIEN DANIEL B | sell | 94,563 |
| Jul 21, 23 | O BRIEN DANIEL B | sell | 9,312 |
| Jul 19, 23 | O BRIEN DANIEL B | sell | 17,647 |
| Jul 20, 23 | O BRIEN DANIEL B | sell | 20,100 |
| Jun 21, 23 | O BRIEN DANIEL B | sell | 4,114 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our FSI coverage
Recent articles, reports, and earnings notes.
No research on FSI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FSI report →Teledyne e2v Introduces Nexora, Its Next-Generation Family of Backside-Illuminated Global Shutter CMOS Image Sensors
gurufocus.com · Sep 22
Financial Comparison: Eastman Chemical (NYSE:EMN) & Flexible Solutions International (NYSE:FSI)
defenseworld.net · Sep 16
FSI ANNOUNCES THE APPOINTMENT OF DR. KIM REID AS DIRECTOR
globenewswire.com · Aug 31
FlightSafety International Reaches Agreement to Acquire Acron Technologies' Commercial Training Solutions
businesswire.com · Aug 26
Flexible Solutions International: I'm Buying The Growing Pains (Rating Upgrade)
seekingalpha.com · Aug 18
Flexible Solutions International, Inc. (FSI) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 17
Flexible Solutions International Inc. (FSI) Reports Q2 Loss, Misses Revenue Estimates
zacks.com · Aug 14
FSI ANNOUNCES SECOND QUARTER, 2026 FINANCIAL RESULTS
globenewswire.com · Aug 14
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.